Is MNKD Worth Buying in 2026?

Mannkind Corporation

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-07

Here’s whether Mannkind Corporation (MNKD) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+6.75% over 10 days); RSI 60 — healthy momentum range; 3-month momentum positive (+26.9%). Concerns: trading below the 200-day MA (long-term downtrend); weak 1-year return of -20.9%. Currently 47.8% off its 52-week high. Score: +1/7.

Ready to act on this? 📈 Trade on Webull

MNKD is trading below its 200-day MA ($4.56) — a key warning sign the longer-term trend is under pressure. An RSI of 59.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -20.9% compares to +24.4% for SPY (trailed the market by 45.3%). The current 47.8% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $7,907 today
vs. S&P 500 (SPY) — same period trailed market by 45.3%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($4.56)
Above 50-day MA ($2.97)
RSI(14) neutral zone (30–70) — currently 59.5
Positive return (-20.9%)
!Within 10% of period high (−47.8%)
Period Range $3.40
$2.23 $6.51
RSI (14) 59.5
0 · OversoldOverbought · 100

Key Metrics

Price$3.40
Period Return-20.9%
Period High$6.51
Period Low$2.23
Drawdown−47.8%
MA-50$2.97
MA-200$4.56
RSI (14)59.5
Avg Volume (30d)6.6M
vs. SPYtrailed by 45.3%
Return Rank#885 of 1245

Trade MNKD

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers